Psychopharmacology Update: What to Do When Evidence-Based Therapies Fail: Treatment-Resistant and Treatment-Refractory Schizophrenia



Date & Location
Thursday, February 28, 2019, 12:00 AM - Friday, February 28, 2020, 11:59 PM

Credits
AMA PRA Category 1 Credits™ (1.00 hours), AMA PRA Category 1 Credits™ Designated (1.00 hours)

Target Audience
Specialties - Neurology and Rehabilitation, Nursing, Psychiatry and Behavioral Health

Overview

About 30% of patients with schizophrenia have positive symptoms that are resistant or refractory to treatments with antipsychotic monotherapy. Physicians should consider the adequacy of the previous drug treatment, adherence to therapy, and the existence of other disorders that may cause psychosis. In addition, some therapies have shown positive or mixed results in clinical trials and may be helpful for some patients.


Registration

To register and review this FREE enduring material activity go to: 

https://www.globalacademycme.com/cme/neurology/what-do-when-evidence-based-therapies-fail

 Participants should read the activity information, review the activity in its entirety, and complete the online post-test and evaluation. Upon completing this activity as designed and achieving a passing score on the post-test. you will be directed to a webpage that will allow you to receive your certificate of credit via email or you may print it out at that time. 

The on line post-test and evaluation can be accessed at https://linyurl.com/TXRST18 


Objectives
At the conclusion of this program, participants should be better able to:

  1. Describe the factors to consider when re-examining the diagnosis of schizophrenia when a patient's positive symptoms do not improve with adequate trials of anti psychotic medications. including clozapine
  2. List requirements for an adequate trial of antipsychotic medication
  3. Describe the data from clinical trials of various adjunctive agents that may be useful for a patient with refractive or treatment-resistant schizophrenia

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint 
providership of the University of Cincinnati and Global Academy for Medical Education.

The University of Cincinnati is accredited by the ACCME to provide continuing education for physicians. 

The University of Cincinnati designates this Live Activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 


Additional Information

Disclaimer Statement

The opinions expressed during the live activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees’ professional development.